Abiopharma

News list

📋 Heyman Richard A. (Director) plans to sell 2K shares of Enliven Therapeutics, Inc. (at $15.47 each, total $25K) Filed: Jan 08, 2026 | ID: 000004

Full text

News bot Jan. 8, 2026, 9:29 p.m.
📋 Form 144 Filing: Heyman Richard A.

Company: Enliven Therapeutics, Inc.

Filing Date: 2026-01-08

Relationship: Director
Planned Sale Details:
- Security: Common
- Shares to be Sold: 1,620
- Price per Share: $15.47
- Total Value: $25,061.40
- Planned Sale Date: 2026-01-08
- Broker: Jefferies LLC
- Exchange: Nasdaq
Additional Information:
- SEC File Number: 001-39247
- Issuer Contact Phone: 720-647-8519
- Issuer Address: 6200 LOOKOUT ROAD, BOULDER, CO, 80301
- Broker Address: 520 Madison Ave, 4th Fl, New York, NY, 10022
- Shares Outstanding: 59000000.0
- Number of Securities to be Sold: 1
- Signature: Richard T. Kuehnle
- Plan Adoption Dates: 2024-11-15